Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Biocon tumbles on reporting 51% fall in Q1 consolidated net profit

28-Jul2017

Biocon tumbles on reporting 51% fall in Q1 consolidated net profit

Biocon is currently trading at Rs. 386.80, down by 12.30 points or 3.08% from its previous closing of Rs. 399.10 on the BSE.

The scrip opened at Rs. 373.80 and has touched a high and low of Rs. 389.70 and Rs. 371.70 respectively. So far 3,82,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 424.15 on 19-Jul-2017 and a 52 week low of Rs. 255.41 on 12-Aug-2016.

Last one week high and low of the scrip stood at Rs. 408.20 and Rs. 371.70 respectively. The current market cap of the company is Rs. 23,208.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 18.80% and 20.53% respectively.

The company has reported a fall of 61.46% in its net profit at Rs 54.50 crore for first quarter ended June 30, 2017 as compared to Rs 141.40 crore for the same quarter in the previous year. Total income of the company decreased 17.43% at Rs 606.70 crore for Q1FY18 as compared to Rs 734.80 crore for the corresponding quarter previous year.

On consolidate basis, the company has reported a fall of 51.20% in its net profit at Rs 81.30 crore for the quarter ended June 30, 2017 as compared to Rs 166.60 crore for the corresponding quarter in the FY17. Total consolidated income of the company decreased by 4.38% at Rs 987.70 crore for quarter under review as compared to Rs 1032.90 crore for the same quarter in the previous year.




Related News

View all news

IndusInd Bank surges on reporting 5% rise in Q2 net profit

IndusInd Bank is currently trading at Rs. 1663.60, up by 36.75 points or 2.26% from its previous closing of Rs. 1626.85 on the BSE.The scrip opened at Rs. 1638.00 and has touched a high and low of Rs.......

Lupin rises with arm partnering with ASHA, NPWH

Lupin is currently trading at Rs. 897.00, up by 16.55 points or 1.88% from its previous closing of Rs. 880.45 on the BSE.The scrip opened at Rs. 889.80 and has touched a high and low of Rs. 910.00 and......

Alembic Pharma surges with receiving USFDA's tentative approval for Alogliptin Tablet

Alembic Pharmaceuticals is currently trading at Rs. 602.35, up by 6.50 points or 1.09% from its previous closing of Rs. 595.85 on the BSE.The scrip opened at Rs. 596.65 and has touched a high and low of......

Top News

View all news

Shalimar Paints lays down foundation of Nashik manufacturing plant

Shalimar Paints has laid down the foundation of a manufacturing unit to be rebuilt in Nashik, in the state of Maharashtra. The company set to commence operations by April 2019 with a planned production......

Delta Corp reports 11% rise in Q2 consolidated net profit

Delta Corp has reported results for second quarter ended September 30, 2018.The company has reported over 2-fold jump in its net profit at Rs 63.51 crore for the quarter under review as compared to Rs......

PNB plans to sell non-core assets worth Rs 8,600 crore during FY19

Punjab National Bank (PNB) has recognized various assets, including its housing finance arm, for sale and hopes to realise Rs 8,600 crore from these non-core assets during the current fiscal. Meanwhile,......